Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2025-12-25 @ 3:26 AM
NCT ID:
NCT04271605
Eligibility Criteria:
Inclusion Criteria:
* Age \> 50 years
* Chronic kidney disease stage 3-4, and estimated glomerular filtration rate \> 20 mL/min/1.73m2
* Fracture Risk Assessment Tool (FRAX®) screening: risk of hip fracture (HF) and major osteoporotic fracture (MOF) (HF: men \> 6%, women \> 7%; MOF: men \> 15%, women \> 12.5%).
* Have ability to sign inform consent and agree with being follow-up for one year.
Exclusion Criteria:
* Have cancer under treatment.
* Have acute coronary syndrome (unstable angina, non ST-elevation myocardial infarction, ST-segment elevation myocardial infarction) or stroke in 3 months. (ST segment is the flat, isoelectric section of the ECG between the end of the S wave and the beginning of the T wave.)
* Limited cognitive or physical function for execute the intervention.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT04271605
Study Brief:
Protocol Section:
NCT04271605